IL7 and cancer: Previous clinical studies of rhIL-7 in HIV-infected or refractory cancer patients revealed that the relative frequency of regulatory T cells (Treg) expressing low-level CD127 was reduced due to IL-7-induced expansion of conventional T-cells [24, 25].